Status | Study |
Not yet recruiting |
Study Name: Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer Condition: Breast Cancer Date: 2017-04-24 Interventions: Drug: Abemaciclib Abemaciclib (LY2835219) has been shown in vitro to be a selective ATP-competitive inhi |
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition: Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin Date: 2017-02-08 |
Recruiting |
Study Name: MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH) Condition: Hereditary Retinoblastoma Date: 2017-01-06 Interventions: Procedure: MRI MRI will be performed each year during 10 years. |
Recruiting |
Study Name: Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma Condition: Retinoblastoma Cataracts Infantile Glaucoma, Congenital Date: 2016-12-28 Interventions: Other: CRADLE |
Not yet recruiting |
Study Name: Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma Condition: Hemodynamic Instability Date: 2016-11-02 Interventions: Drug: Tetracaine 0.5% One drop |
Not yet recruiting |
Study Name: G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor Condition: Acute Myeloid Leukemia Acute Lymphoid Leukemia Lymphoma Date: 2016-10-08 Interventions: Biological: GM-CSF Granulocyte |
Recruiting |
Study Name: Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) Condition: Retinoblastoma Date: 2016-08-09 Interventions: Other: Observation no post ope |
Recruiting |
Study Name: Conservative Treatments of Retinoblastoma Condition: Retinoblastoma Children Retinal Neop Date: 2016-07-27 Interventions: Drug: VP16, carboplatin System |
Recruiting |
Study Name: Understanding Communication in Healthcare to Achieve Trust (U-CHAT) Condition: Neuroblastoma Sarcoma Carcinoma Date: 2016-07-20 |
Recruiting |
Study Name: Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma Condition: Retinoblastoma Date: 2016-06-02 Interventions: Drug: Carboplatin Carboplatin |